Protecting the bladder from cyclophosphamide with mesna.
Explore the source record for details and available documents.
Cyclophosphamide↗
Biomedical subjects
Publications and source records attributed to B Sidau.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Cyclophosphamide was given as IV doses of 50 mg/kg/day on each of four successive days as treatment for ovarian and lung cancer. Blood samples were taken at regular intervals and analysed for cyclophosphamide by gas liquid chromatography. The plasma half-lives (t 1/2) and volumes of distribution (V D) were calculated for each of the treatment days; t 1/2 was found to decrease with subsequent doses whereas V D was not significantly changed.
Explore the source record for details and available documents.